Company Filing History:
Years Active: 2022
Title: Hae Young Suh: Innovator in Stem Cell Research
Introduction
Hae Young Suh is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of stem cell research, particularly in the development of therapeutic methods for neurological diseases. His innovative work has the potential to transform treatment options for patients suffering from various neurological conditions.
Latest Patents
Hae Young Suh holds a patent for a method that introduces hepatocyte growth factor (HGF) and neurogenin 1 into mesenchymal stem cells. This invention relates to an adult stem cell line that has been modified with an HGF gene and a neurogenic transcription factor gene from the bHLH family. The patent outlines a preparation method for this adult stem cell line, as well as a composition designed for the prevention or treatment of neurological diseases. The adult stem cells developed through this method can be utilized to address chronic impairments caused by cell death following strokes. This innovation holds promise for clinical applications in cell replacement therapy and gene therapy for conditions such as Parkinson's disease, Alzheimer's disease, spinal cord injuries, and strokes.
Career Highlights
Hae Young Suh is associated with Cell & Brain Co., Ltd., where he continues to advance his research in stem cell technology. His work is characterized by a commitment to improving therapeutic strategies for neurological disorders. With a focus on innovative solutions, he has established himself as a key figure in the field.
Collaborations
Hae Young Suh collaborates with notable colleagues, including Sung Soo Kim and Seung Wan Yoo. These partnerships enhance the research efforts at Cell & Brain Co., Ltd. and contribute to the advancement of stem cell therapies.
Conclusion
Hae Young Suh's contributions to stem cell research and his innovative patent for treating neurological diseases underscore his importance in the scientific community. His work not only offers hope for patients but also paves the way for future advancements in medical therapies.